Jonny; Sitepu, E.C.; Hernowo, B.A.; Chiuman, L.; Lister, I.N.E.; Putranto, T.A.
Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10, Tumor Necrosis Factor α) in Diabetic Kidney Disease (DKD). Curr. Issues Mol. Biol. 2024, 46, 13662-13674.
https://doi.org/10.3390/cimb46120816
AMA Style
Jonny, Sitepu EC, Hernowo BA, Chiuman L, Lister INE, Putranto TA.
Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10, Tumor Necrosis Factor α) in Diabetic Kidney Disease (DKD). Current Issues in Molecular Biology. 2024; 46(12):13662-13674.
https://doi.org/10.3390/cimb46120816
Chicago/Turabian Style
Jonny, Enda Cindylosa Sitepu, Bhimo Aji Hernowo, Linda Chiuman, I Nyoman Ehrich Lister, and Terawan Agus Putranto.
2024. "Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10, Tumor Necrosis Factor α) in Diabetic Kidney Disease (DKD)" Current Issues in Molecular Biology 46, no. 12: 13662-13674.
https://doi.org/10.3390/cimb46120816
APA Style
Jonny, Sitepu, E. C., Hernowo, B. A., Chiuman, L., Lister, I. N. E., & Putranto, T. A.
(2024). Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10, Tumor Necrosis Factor α) in Diabetic Kidney Disease (DKD). Current Issues in Molecular Biology, 46(12), 13662-13674.
https://doi.org/10.3390/cimb46120816
_Kim.png)
